Health Care·Health Care Equipment·$107.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.07 | N/A | +5.95% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.07 | N/A | +5.95% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in the company's strategic direction. They emphasized their commitment to growth despite not providing specific guidance.
Management highlighted strong performance in key product areas.
They noted ongoing investments in innovation and market expansion.
This earnings report indicates that Medtronic is performing well, particularly in terms of earnings per share, which exceeded expectations. The positive stock reaction of 4.77% suggests that investors are encouraged by the company's performance and management's outlook. However, the lack of revenue data and guidance may leave some investors cautious about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ZTO EXPRESS CAYMAN I Class A ADR
Nov 20, 2017